Sanara MedTech Inc.
Sanara MedTech Inc. (Nasdaq: SMTI) develops and commercializes medical technologies for surgical care, primarily soft tissue repair and bone fusion products used in operating rooms and other sterile settings. Its customers include hospitals and ambulatory surgical centers, where surgeons use products such as… From the company’s description.
Over the twelve months to Jun 30, 2026, Sanara MedTech Inc. reported revenue of $109.79M, up 12.9% from a year earlier, and a net loss of $32.02M. Its operating margin was 12.6%, and operations generated $5.70M in cash. In fiscal 2025, it reported revenue of $103.12M, up 19.0% from fiscal 2024, and a net loss of $37.57M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Sanara MedTech Inc. does
In the company’s own words
Sanara MedTech Inc. (Nasdaq: SMTI) develops and commercializes medical technologies for surgical care, primarily soft tissue repair and bone fusion products used in operating rooms and other sterile settings. Its customers include hospitals and ambulatory surgical centers, where surgeons use products such as CellerateRX Surgical, a hydrolyzed collagen powder for surgical wound management, and BIASURGE, a wound irrigation solution. Its portfolio also includes bone graft products BiFORM, ACTIGEN and ALLOCYTE Plus, as well as TEXAGEN amniotic membrane allograft and FORTIFY TRG tissue repair graft. The company sells through surgical specialty distributors and its field sales representatives; by the end of 2025, its products had contracts with more than 4,000 hospitals. Sanara operates as a single reportable segment focused on surgical products after discontinuing its Tissue Health Plus value-based wound care operations in 2025. It also conducts research and development through Rochal Technologies and relies on contract manufacturers rather than operating its own manufacturing facilities.
Company details
- Sector
- Health Care
- Industry (SIC)
- Medical Instruments
- Headquarters
- FORT WORTH, TX
- Fiscal year end
- December
- CIK
- 714256
- SIC
- 3842
Financial performance, year by year
Fiscal 2011–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Sanara MedTech Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Sanara MedTech Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Sanara MedTech Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Sanara MedTech Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Sanara MedTech Inc.'s last four quarterly filings that the numbers alone won't show?”